Update Ann_Kwong.yaml

data/members/Ann_Kwong.yaml

@@ -6,13 +6,13 @@ institution: Kwong Pharma Consulting, LLC
 img: ann-kwong.jpg
 webpage: "https://www.linkedin.com/in/ann-d-kwong-phd-0060154/"
 description: |
-  Ann has over 30 years of experience in in the biopharmaceutical industry and has helped move multiple 
-  antiviral compounds into the clinic. At Vertex Pharmaceuticals, Ann played a leading role in the 
+  Ann Kwong, Ph.D. has over 30 years of experience in in the biopharmaceutical industry and has helped move multiple 
+  antiviral compounds into the clinic. At Vertex Pharmaceuticals, Dr. Kwong played a leading role in the 
   research, development, and commercialization of telaprevir- an HCV protease inhibitor that received 
-  the Prix Galien Award for Best Pharmaceutical Agent in 2012. Ann also designed Vertex’s influenza virus
+  the Prix Galien Award for Best Pharmaceutical Agent in 2012. Dr. Kwong also designed Vertex’s influenza virus
   program, which led to the development of pimodivir, a first in class PB2 inhibitor; she was awarded 
   the Gertrude Elion Memorial Award in 2020 by the International Society for Antiviral Research. 
   Ann founded Trek Therapeutics to develop affordable HCV treatments; and was the EVP of R&D at 
-  Dewpoint Therapeutics. She is currently Principal at Kwong Pharma Consulting, LLC.  
-  Ann is a co-author or inventor on numerous publications and patents and received her BA in Biology 
-  and PhD in virology from the University of Chicago. 
+  Dewpoint Therapeutics. She is currently Principal at Kwong Pharma Consulting, LLC. Dr. Kwong is a
+  co-author or inventor on numerous publications and patents and received her BA in Biology and PhD 
+  in virology from the University of Chicago.